Illexcor Therapeutics, Inc.
Biotechnology company · Henrico, Virginia, United States
Illexcor Therapeutics, Inc. is a biotechnology company headquartered in Henrico, Virginia, United States. Its earliest recorded incorporation is in 2026. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $5.6 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2026.
Illexcor Therapeutics at a glance
What does Illexcor Therapeutics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $5.6 million in total (2020 to 2023). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $13 million sold (2026).
Frequently asked questions about Illexcor Therapeutics
Where is Illexcor Therapeutics headquartered?
Illexcor Therapeutics, Inc. is headquartered in Henrico, Virginia, United States.
What does Illexcor Therapeutics do?
Illexcor Therapeutics, Inc. is a biotechnology company.
When was Illexcor Therapeutics founded?
The earliest incorporation on record for Illexcor Therapeutics, Inc. is in 2026, according to public company registers.
Similar companies
- Illexcor Holdings, LLCHenrico, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences